PAXTRAVA

DEAD

Serial Number

97270111

Owner

Ocular Therapeutix, Inc.

Attorney

Matthew P. Hintz, Esq.

Filing Date

Feb 16, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

PAXTRAVA Trademark

Serial Number: 97270111

PAXTRAVA is a trademark filed by Ocular Therapeutix, Inc. on February 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Ocular Therapeutix, Inc. (20 trademarks)

36 Crosby Drive, Suite 101
Bedford, MA 01730

Entity Type: 03

Legal Representation

Attorney of Record

Matthew P. Hintz, Esq.

1,345 trademarks filed View all →

Correspondence Address

Matthew P. Hintz, Esq. LOWENSTEIN SANDLER LLP

ONE LOWENSTEIN DRIVE

ROSELAND, NJ 07068

United States

Trademark Details

Filing Date

February 16, 2022

Registration Date

Not Registered

Published for Opposition

April 25, 2023

Goods & Services

Punctum plug drug delivery insert sold filled with pharmaceutical preparations for the treatment of eye diseases and conditions; Punctum plug drug delivery insert sold filled with pharmaceutical preparations for the treatment of glaucoma; Punctum plug drug delivery insert sold filled with pharmaceutical preparations for lowering intraocular pressure; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of glaucoma; Pharmaceutical preparations for the treatment of intraocular pressure.

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jan 26, 2026 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jan 26, 2026 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2025 EXRA

SOU EXTENSION 4 GRANTED

Jun 9, 2025 EX4G

SOU EXTENSION 4 FILED

Jun 9, 2025 EXT4

SOU TEAS EXTENSION RECEIVED

Jun 9, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 3 GRANTED

Dec 6, 2024 EX3G

SOU EXTENSION 3 FILED

Dec 6, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Dec 6, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 13, 2024 EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 31, 2024 EXRA

SOU EXTENSION 2 GRANTED

May 30, 2024 EX2G

SOU EXTENSION 2 FILED

May 30, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

May 30, 2024 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 24, 2024 TCCA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 24, 2024 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 24, 2024 COAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 5, 2023 EXRA

SOU EXTENSION 1 GRANTED

Dec 1, 2023 EX1G

SOU EXTENSION 1 FILED

Dec 1, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 1, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 20, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 25, 2023 NPUB

PUBLISHED FOR OPPOSITION

Apr 25, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 5, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 17, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 17, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 17, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 17, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 17, 2023 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 2, 2022 GNRN

NON-FINAL ACTION E-MAILED

Dec 2, 2022 GNRT

NON-FINAL ACTION WRITTEN

Dec 2, 2022 CNRT

ASSIGNED TO EXAMINER

Nov 30, 2022 DOCK

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Oct 10, 2022 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 10, 2022 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Oct 10, 2022 COAR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 22, 2022 NWOS

NEW APPLICATION ENTERED

Feb 19, 2022 NWAP

Related Trademarks

More from this Owner

OCUCARE

ELUTYX

OCULAR THERAPEUTIX

More in Same Class

VERU

5 AOX SHIELD ANTIOXIDANT DÉFENSE ANTIOXYDANTE